Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-05

Clinical Trial Update: Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation [Phase 3]

View source ↗

Summary

Phase 3 trial investigating propranolol as an anxiolytic to reduce sedative use in critically ill adults on mechanical ventilation; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propranolol (propranolol)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Mechanical Ventilation, Sedation | Phase 3 | Status: COMPLETED